Haoliang Zhang
99 West Huaihai Road
Xuzhou, 221002, China
Xuzhou, 221002, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
EphA2 specific chimeric antigen receptor engineered T cells for the treatment of prostate cancer.
Journal: Translational oncology
Published: January 22, 2024
Ephrin-A2 promotes prostate cancer metastasis by enhancing angiogenesis and promoting EMT.
Journal: Journal of cancer research and clinical oncology
Published: November 17, 2020
Diagnostic value of DACT-2 methylation in serum of prostate cancer patients.
Journal: Annals of palliative medicine
Published: July 28, 2020
Plasma Exosomal Long Noncoding RNA lnc-SLC2A12-10:1 as a Novel Diagnostic Biomarker for Gastric Cancer.
Journal: OncoTargets and therapy
Published: March 12, 2020
Serum Exosomal Long Noncoding RNA pcsk2-2:1 As A Potential Novel Diagnostic Biomarker For Gastric Cancer.
Journal: OncoTargets and therapy
Published: August 28, 2019
Exosomal long noncoding RNA lnc-GNAQ-6:1 may serve as a diagnostic marker for gastric cancer.
Journal: Clinica chimica acta; international journal of clinical chemistry
Published: July 15, 2019
Combined treatment of ABT199 and irinotecan suppresses KRAS-mutant lung cancer cells.
Journal: Gene
Published: October 15, 2018
Exosomal ephrinA2 derived from serum as a potential biomarker for prostate cancer.
Journal: Journal of Cancer
Published: January 29, 2018
Eph/ephrin family anchored on exosome facilitate communications between cells.
Journal: Cell biology international
Published: October 19, 2017
Showing 1-10 of 10
Last Updated: 09/26/2026